279 related articles for article (PubMed ID: 28859982)
1. Role of interleukin (IL)-17 and T-helper (Th)17 cells in cancer.
Song Y; Yang JM
Biochem Biophys Res Commun; 2017 Nov; 493(1):1-8. PubMed ID: 28859982
[TBL] [Abstract][Full Text] [Related]
2. IL-17, IL-21, and IL-22 Cytokines of T Helper 17 Cells in Cancer.
Nalbant A
J Interferon Cytokine Res; 2019 Jan; 39(1):56-60. PubMed ID: 30562123
[TBL] [Abstract][Full Text] [Related]
3. Interleukin-17 acts as double-edged sword in anti-tumor immunity and tumorigenesis.
Qian X; Chen H; Wu X; Hu L; Huang Q; Jin Y
Cytokine; 2017 Jan; 89():34-44. PubMed ID: 26883678
[TBL] [Abstract][Full Text] [Related]
4. Th17 Cell Plasticity and Functions in Cancer Immunity.
Guéry L; Hugues S
Biomed Res Int; 2015; 2015():314620. PubMed ID: 26583099
[TBL] [Abstract][Full Text] [Related]
5. Innate and adaptive interleukin-17-producing lymphocytes in chronic inflammatory lung disorders.
Vanaudenaerde BM; Verleden SE; Vos R; De Vleeschauwer SI; Willems-Widyastuti A; Geenens R; Van Raemdonck DE; Dupont LJ; Verbeken EK; Meyts I
Am J Respir Crit Care Med; 2011 Apr; 183(8):977-86. PubMed ID: 21097694
[TBL] [Abstract][Full Text] [Related]
6. T helper 17 (Th17) cells and interleukin-17 (IL-17) in cancer.
Chang SH
Arch Pharm Res; 2019 Jul; 42(7):549-559. PubMed ID: 30941641
[TBL] [Abstract][Full Text] [Related]
7. [Do Th17 cells play an important role in the pathogenesis and prognosis of ovarian cancer?].
Winkler I; Gogacz M; Rechberger T
Ginekol Pol; 2012 Apr; 83(4):295-300. PubMed ID: 22712263
[TBL] [Abstract][Full Text] [Related]
8. The paradox of Th17 cell functions in tumor immunity.
Asadzadeh Z; Mohammadi H; Safarzadeh E; Hemmatzadeh M; Mahdian-Shakib A; Jadidi-Niaragh F; Azizi G; Baradaran B
Cell Immunol; 2017 Dec; 322():15-25. PubMed ID: 29103586
[TBL] [Abstract][Full Text] [Related]
9. IL-17+Foxp3+ T cells: an intermediate differentiation stage between Th17 cells and regulatory T cells.
Du R; Zhao H; Yan F; Li H
J Leukoc Biol; 2014 Jul; 96(1):39-48. PubMed ID: 24744433
[TBL] [Abstract][Full Text] [Related]
10. Myeloid derived suppressor cells (MDSCs) can induce the generation of Th17 response from naïve CD4+ T cells.
Chatterjee S; Das S; Chakraborty P; Manna A; Chatterjee M; Choudhuri SK
Immunobiology; 2013 May; 218(5):718-24. PubMed ID: 22995935
[TBL] [Abstract][Full Text] [Related]
11. Tumor-infiltrating CD4+ Th17 cells produce IL-17 in tumor microenvironment and promote tumor progression in human gastric cancer.
Iida T; Iwahashi M; Katsuda M; Ishida K; Nakamori M; Nakamura M; Naka T; Ojima T; Ueda K; Hayata K; Nakamura Y; Yamaue H
Oncol Rep; 2011 May; 25(5):1271-7. PubMed ID: 21369705
[TBL] [Abstract][Full Text] [Related]
12. Targeting the interleukin-17 immune axis for cancer immunotherapy.
Vitiello GA; Miller G
J Exp Med; 2020 Jan; 217(1):. PubMed ID: 31727783
[TBL] [Abstract][Full Text] [Related]
13. IL-17 producing innate lymphoid cells 3 (ILC3) but not Th17 cells might be the potential danger factor for preeclampsia and other pregnancy associated diseases.
Barnie PA; Lin X; Liu Y; Xu H; Su Z
Int J Clin Exp Pathol; 2015; 8(9):11100-7. PubMed ID: 26617829
[TBL] [Abstract][Full Text] [Related]
14. [The role of Th17 cells in anti-cancer immunity].
Hus I; Maciag E; Roliński J
Postepy Hig Med Dosw (Online); 2010 May; 64():244-50. PubMed ID: 20498501
[TBL] [Abstract][Full Text] [Related]
15. Interleukin 2-mediated conversion of ovarian cancer-associated CD4+ regulatory T cells into proinflammatory interleukin 17-producing helper T cells.
Leveque L; Deknuydt F; Bioley G; Old LJ; Matsuzaki J; Odunsi K; Ayyoub M; Valmori D
J Immunother; 2009; 32(2):101-8. PubMed ID: 19238008
[TBL] [Abstract][Full Text] [Related]
16. Interleukin-17-producing cell infiltration in the breast cancer tumour microenvironment is a poor prognostic factor.
Chen WC; Lai YH; Chen HY; Guo HR; Su IJ; Chen HH
Histopathology; 2013 Aug; 63(2):225-33. PubMed ID: 23738752
[TBL] [Abstract][Full Text] [Related]
17. Increased IL-17-producing CD4(+) T cells in patients with esophageal cancer.
Chen D; Hu Q; Mao C; Jiao Z; Wang S; Yu L; Xu Y; Dai D; Yin L; Xu H
Cell Immunol; 2012; 272(2):166-74. PubMed ID: 22082565
[TBL] [Abstract][Full Text] [Related]
18. IL-27 in tumor immunity and immunotherapy.
Murugaiyan G; Saha B
Trends Mol Med; 2013 Feb; 19(2):108-16. PubMed ID: 23306374
[TBL] [Abstract][Full Text] [Related]
19. Interleukin 17A: toward a new understanding of psoriasis pathogenesis.
Lynde CW; Poulin Y; Vender R; Bourcier M; Khalil S
J Am Acad Dermatol; 2014 Jul; 71(1):141-50. PubMed ID: 24655820
[TBL] [Abstract][Full Text] [Related]
20. Unlike αβ T cells, γδ T cells, LTi cells and NKT cells do not require IRF4 for the production of IL-17A and IL-22.
Raifer H; Mahiny AJ; Bollig N; Petermann F; Hellhund A; Kellner K; Guralnik A; Reinhard K; Bothur E; Huber M; Bauer S; Löhning M; Kiss EA; Ganal SC; Diefenbach A; Korn T; Lohoff M
Eur J Immunol; 2012 Dec; 42(12):3189-201. PubMed ID: 22961652
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
